LL-37

Research

LL-37 (Cathelicidin Antimicrobial Peptide)

Aliases
hCAP-18 fragment, Cathelicidin
Administration
Topical (research), Subcutaneous injection (research)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Limited data on human side effects

This compound has not been extensively studied in humans, so its full side-effect profile remains uncertain.

Topical irritation possible

Mild redness or irritation can occur at the site of topical application.